AHRR, a protein that negatively controls AHR-expressed genes by competing with AHR to bind to heterobetaine-responsive elements [107] is downregulated in several tumor types, including colon, breast, gastric, cervical, and ovarian cancers. This evidence concerns the gene AHR and neoplasm.